// App-Quantinova.ai

P739 : The progression of inflammatory bowel disease throughout Latin America: a systematic review

Researchers

Presenter

  • P Kotze

Principal Investigators

  • F Underwood

  • A Damiao

  • J Ferraz

  • R Saad-Hossne

  • M Toro

  • B Iade

  • F Bosques-Padilla

  • F Teixeira

  • F Juliao-Baos

  • D Simian

  • S Ghosh

  • R Panaccione

  • G Kaplan

Medical Centers

  • Catholic University of Paraná, IBD Outpatient Clinics- Colorectal Surgery Unit, Curitiba, Brazil

  • University of Calgary, Division of Gastroenterology & Hepatology, Calgary Alberta, Canada

  • University of Sao Paulo, Gastroenterology, Sao Paulo, Brazil

  • UNESP, Digestive Surgery, Botucatu, Brazil

  • Cuyo National University, Gastroenterology, Mendoza, Argentina

  • Hospital de Clínicas, Gastroenterology, Montevideo, Uruguay

  • Autonomous University of Nuevo Leon, Gastroenterology, Monterey, Mexico

  • Clinica Gastrosaude, IBD unit, Marilia, Brazil

  • Hospital Pablo Tobon Uribe, Gastroenterology, Medellin, Colombia

  • Clinica Las Condes, Santiago, Chile

  • NIHR Biomedical Research Centre, Institute of translational Medicine, Birmingham, UK

Locations

  • Brazil

  • Canada

  • Argentina

  • Uruguay

  • Mexico

  • Colombia

  • Chile

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A